IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System

  • 产品详情
  • Product Features


    1.    World’s thinnest 

    70 micron total thickness, the world‘s only iron-based bioresorbable technology path. 

    2.    Excellent operation performance

    The scaffold is compatible with 5F catheter. The nominal diameter of post-expansion limit is  +0.75mm.

    3.    Good visibility

    Two sets of gold radiopaque markers are located at both ends of scaffold to enhance the visibility.

    4.    Rapid endothelialization

    -1 month

    5.    High drug utilization

    The content of sirolimus is 1.4μg/mm2, with most of the drug being located on abluminal surface of the struts.

    6.    Reasonable degradation profile

    Effective support for 6 months and  complete degradation in about 1.5 years.


    Technical Data


    Product Specification


    Size Specification Table


    Note:“√”indicates that there is a scaffold of this size;“/”indicates that there is any scaffold of this size.

    产品特点


    1.    全球最薄

    70微米总厚,全球唯一铁基可吸收技术路径 

    2.    操控性能优异

    5F导管兼容,后扩极限为名义直径+0.75mm

    3.    可视性好

    支架两端各设一组黄金显影点,增强支架可视性

    4.    快速完全内皮化

    ~1个月

    5.    高药物利用率

    雷帕霉素含量,1.4μg/mm2,药物富集在支架杆离腔侧

    6.    合理的降解曲线

    6个月有效支撑,~1.5年全降解


    产品规格


    可吸收药物洗脱冠脉支架尺寸规格表


    注:“√”表示有该尺寸规格的支架;“/”表示没有该尺寸规格的支架